信佳國際(00912.HK)中期純利減少13%至2750萬港元 中期息6港仙
格隆匯11月27日丨信佳國際(00912.HK)公佈,截至2019年9月30日止6個月,公司收益8.8億港元,同比增長2%;公司擁有人應占溢利2750萬港元,同比減少13%;每股盈利9.68港仙,中期股息每股6港仙。
期間電子產品業務繼續為公司提供穩定收益,期內銷售額為740,300,000港元(上年同期:727,000,000港元),按年增加1.8%,佔總銷售額84.1%。增長動力主要來自新產品,包括為美國新經濟客户Mobilogix,Inc.開發應用物聯網技術的資產追蹤器。Mobilogix不只是信佳新客户,更是集團投資項目之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.